Ann: Trading Halt, page-18

The big financial picture with this stock IMO is annual revenue is circa $1.5m and wages and raw materials are circa $11m.
Accountants match costs and expenses so the company is selling its product at circa less than 15% of cost. What you see here is what is happening, there is no "but".
Either RFX hugely reduce unit cost of production (by increasing volumes immensely to get scale efficiencies, or lowering imput costs dramatically)
This ratio existed prior to the last capital raising at 4.2 cents, and continues today.
This company needs to, as a matter of existential urgency, address this issue.
The question now, and at the last CR issue was: can it address the issue before it runs out of money?